pi3k-akt-signaling

PI3K/AKT Signaling Pathway in Neurodegeneration

Overview

The PI3K/AKT signaling pathway is a critical pro-survival cascade that regulates neuronal survival, metabolism, synaptic plasticity, and protein homeostasis[@brazil2024]. Dysregulation of this pathway significantly contributes to neuronal death in [Alzheimer's disease](/diseases/alzheimers-disease) (AD), [Parkinson's disease](/diseases/parkinsons-disease) (PD), and other neurodegenerative disorders[@gong2023]. The pathway represents a crucial intersection between neurotrophic factor signaling and cellular survival mechanisms, making it a central focus for understanding neurodegeneration and developing therapeutic interventions[@kimelberg2022].

AKT (also known as PKB) is a serine/threonine protein kinase that promotes cell survival through multiple downstream effectors[@manning2007]. The PI3K/AKT signaling cascade is one of the most important cell survival pathways in neurons, linking extracellular growth factor signals to intracellular survival programs[@hetman2004]. This pathway is particularly important in the central nervous system, where post-mitotic neurons require robust survival signaling to maintain function throughout the lifespan[@zhang2024].

Signaling Cascade Architecture

Activation Triggers

The pathway is activated by various extracellular signals that bind to receptor tyrosine kinases (RTKs) or cytokine receptors[@cheng2023]:

PI3K/AKT Signaling Pathway in Neurodegeneration

Overview

The PI3K/AKT signaling pathway is a critical pro-survival cascade that regulates neuronal survival, metabolism, synaptic plasticity, and protein homeostasis[@brazil2024]. Dysregulation of this pathway significantly contributes to neuronal death in [Alzheimer's disease](/diseases/alzheimers-disease) (AD), [Parkinson's disease](/diseases/parkinsons-disease) (PD), and other neurodegenerative disorders[@gong2023]. The pathway represents a crucial intersection between neurotrophic factor signaling and cellular survival mechanisms, making it a central focus for understanding neurodegeneration and developing therapeutic interventions[@kimelberg2022].

AKT (also known as PKB) is a serine/threonine protein kinase that promotes cell survival through multiple downstream effectors[@manning2007]. The PI3K/AKT signaling cascade is one of the most important cell survival pathways in neurons, linking extracellular growth factor signals to intracellular survival programs[@hetman2004]. This pathway is particularly important in the central nervous system, where post-mitotic neurons require robust survival signaling to maintain function throughout the lifespan[@zhang2024].

Signaling Cascade Architecture

Activation Triggers

The pathway is activated by various extracellular signals that bind to receptor tyrosine kinases (RTKs) or cytokine receptors[@cheng2023]:

Growth Factors:

• BDNF (Brain-Derived Neurotrophic Factor): Activates TrkB receptor, providing critical survival signals for cortical and hippocampal neurons[@liu2023]
• IGF-1 (Insulin-like Growth Factor 1): Regulates neuronal metabolism and survival through IGF-1 receptor signaling[@wang2024]
• NGF (Nerve Growth Factor): Essential for sympathetic and sensory neuron survival, activates TrkA signaling[@cohen2023]
• GDNF (Glial Cell Line-Derived Neurotrophic Factor): Critical for dopaminergic neuron survival in the substantia nigra pars compacta[@ma2023]

• IL-6 family cytokines activate the pathway through GP130 receptor signaling[@huang2024]
• TNF can activate PI3K/AKT in certain cellular contexts, with complex pro-survival and pro-inflammatory effects[@sanchez2023]

• Insulin receptor activation provides metabolic regulation and survival signaling[@xu2024]
• Cross-talk between neuronal insulin signaling and neurotrophic pathways is important for cognitive function[@li2023]

PI3K Activation and Lipid Signaling

Class I PI3K Isoforms:

The class I PI3K isoforms are heterodimers consisting of a p85 regulatory subunit and a p110 catalytic subunit[@chen2024]:

• PI3Kα (PIK3CA): Contains p110α catalytic subunit, broadly expressed and important for growth factor signaling[@park2023]
• PI3Kβ (PIK3CB): Contains p110β, primarily expressed in blood cells and some neuronal populations[@zhang2024a]
• PI3Kγ (PIK3CG): Predominantly in immune cells, involved in inflammatory responses[@watanabe2023]
• PI3Kδ (PIK3CD): Leukocyte-specific isoform[@sun2024]

The activation sequence proceeds as follows[@liu2023a]:

The lipid phosphatase PTEN (Phosphatase and Tensin Homolog) opposes PI3K activity by dephosphorylating PIP3 back to PIP2, providing crucial negative regulation of the pathway[@thompson2024].

AKT Activation and Kinase Cascade

PDK1 (3-Phosphoinositide-Dependent Protein Kinase-1):

PDK1 is essential for AKT activation through phosphorylation at Thr308 in the activation loop[@koh2023]:

• PDK1 phosphorylates AKT at Thr308, providing partial activation
• Membrane recruitment is necessary for PDK1-mediated phosphorylation
• PDK1 activity is constitutive, but membrane localization ensures proper timing

mTORC2 phosphorylates AKT at Ser473 in the hydrophobic motif[@vanhaesebroeck2020]:

• This phosphorylation is required for full AKT activation
• mTORC2 regulates AKT substrate specificity
• Growth factor signaling enhances mTORC2 activity

AKT exists in three isoforms with distinct tissue distributions[@stambolic2001]:

• AKT1 (PKBα): Widely expressed, important for embryonic development
• AKT2 (PKBβ): Important for metabolic functions
• AKT3 (PKBγ): Highly expressed in brain, crucial for neuronal function

Downstream Effectors

GSK-3β (Glycogen Synthase Kinase-3 Beta):

GSK-3β is a critical downstream target of AKT[@sarbassov2006]:

• AKT phosphorylates GSK-3β at Ser9, inhibiting its kinase activity
• This provides a key link between PI3K/AKT signaling and tau phosphorylation
• GSK-3β dysregulation contributes to both amyloid and tau pathology in AD[@atkins2022]

BAD is a pro-apoptotic BH3-only protein[@jope2022]:

• AKT phosphorylates BAD at Ser136, promoting its sequestration by 14-3-3 proteins
• This prevents BAD from inhibiting anti-apoptotic BCL-2 proteins
• Neuronal survival requires BAD inactivation through phosphorylation[@cheng2022]

FOXOs are transcription factors that promote pro-apoptotic gene expression[@calnan2008]:

• AKT phosphorylates FOXO1 and FOXO3a, promoting their cytoplasmic retention
• Phosphorylated FOXOs are sequestered in the cytoplasm by 14-3-3 proteins
• This prevents transcription of genes like BIM, PUMA, and FasL[@kim2009]

mTOR is a central regulator of cell growth and metabolism[@saxton2017]:

• AKT activates mTORC1 through multiple mechanisms (TSC2 inhibition, PRAS40 phosphorylation)
• mTORC1 regulates protein synthesis through S6K1 and 4E-BP1
• mTORC1 also inhibits [autophagy](/mechanisms/autophagy), linking growth factor signaling to protein homeostasis[@kuma2022]

AKT can phosphorylate and activate CREB[@carlezon2000]:

• CREB activation promotes expression of survival genes
• CREB-mediated transcription is important for neuronal plasticity and memory
• BDNF expression is partly regulated by CREB[@lonze2002]

PI3K/AKT in Alzheimer's Disease

Dysregulation in AD Brain

Multiple alterations in the PI3K/AKT pathway characterize [Alzheimer's disease](/diseases/alzheimers-disease) brain[@talbot2012]:

Reduced AKT Signaling:

• Decreased AKT phosphorylation at both Thr308 and Ser473 in AD hippocampus[@liu2023b]
• Impaired PI3K activity in cortical and hippocampal regions
• Reduced growth factor signaling through TrkB and IGF-1 receptors

• Increased PTEN expression in AD brain correlates with reduced PIP3 levels
• PTEN mutations or inhibitors protect against amyloid-β toxicity in models[@knafo2022]

• Reduced BDNF levels in AD hippocampus and cortex[@peng2023]
• Impaired IGF-1 signaling contributes to neuronal vulnerability
• Decreased neurotrophic support exacerbates neurodegeneration

Connection to AD Pathogenesis

Amyloid-β Effects:

Amyloid-β (Aβ) impairs PI3K/AKT signaling through multiple mechanisms[@shankar2008]:

• Aβ oligomers inhibit PI3K activity at synapses
• Synaptic PI3K/AKT dysfunction contributes to memory deficits
• Aβ-induced [oxidative stress](/mechanisms/oxidative-stress-neurodegeneration) inactivates AKT signaling

The relationship between PI3K/AKT and tau is complex[@avila2006]:

• AKT regulates GSK-3β activity, which directly phosphorylates tau
• Tau pathology disrupts postsynaptic signaling including PI3K/AKT
• Hyperphosphorylated tau may sequester AKT, impairing its function[@li2022]

PI3K/AKT critically regulates synaptic plasticity[@horwood2023]:

• AKT regulates AMPA receptor trafficking during LTP
• Synaptic PI3K/AKT signaling is required for memory consolidation
• Synaptic deficits in AD correlate with PI3K/AKT dysregulation

Therapeutic Potential

AKT Activators:

Direct and indirect strategies to activate AKT are being explored[@lassen2022]:

• Phosphatase inhibitors that preserve AKT phosphorylation
• Growth factor mimetics that enhance upstream signaling
• Allosteric AKT activators in development

Targeting downstream GSK-3β offers therapeutic potential[@martinez2021]:

• Reduces tau phosphorylation and aggregation
• Improves cognitive function in AD models
• Multiple inhibitors in clinical trials for AD and bipolar disorder[@avila2022]

mTOR inhibitors like rapamycin show neuroprotective effects[@bove2011]:

• Induction of [autophagy](/mechanisms/autophagy) to clear protein aggregates
• Enhanced clearance of Aβ through [autophagy](/mechanisms/autophagy)
• Potential for combination with other therapeutic approaches[@liu2024]

PI3K/AKT in Parkinson's Disease

Dopaminergic Neuron Survival

The PI3K/AKT pathway is particularly important for dopaminergic neuron survival[@surmeier2017]:

• High basal PI3K/AKT activity in substantia nigra pars compacta (SNc)
• Dopaminergic neurons are vulnerable when pathway is compromised
• Growth factor dependence makes these neurons susceptible to PI3K/AKT dysfunction

GDNF Signaling

GDNF provides critical survival signaling for dopaminergic neurons[@airavaara2019]:

• GDNF activates RET receptor tyrosine kinase
• PI3K/AKT signaling is the primary survival pathway downstream of RET
• GDNF and related factors have been tested clinically in PD patients[@bartus2013]

α-Synuclein Connection

α-Synuclein pathology affects PI3K/AKT signaling[@chen2022]:

• α-Synuclein oligomers impair PI3K/AKT signaling
• Reduced neuronal survival signaling in PD models
• PI3K/AKT dysregulation may contribute to α-synuclein propagation

Mitochondrial Function

PI3K/AKT regulates mitochondrial function and dynamics[@rosario2022]:

• AKT promotes glucose uptake and mitochondrial biogenesis
• Mitochondrial dynamics are regulated through AKT signaling
• Anti-apoptotic effects include regulation of BCL-2 family proteins

PI3K/AKT in Other Neurodegenerative Diseases

[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) (ALS)

PI3K/AKT signaling alterations in ALS include[@van2023]:

• Motor neuron vulnerability related to growth factor dependence
• Mutations in PI3K pathway genes identified in familial ALS
• Growth factor therapy approaches showing promise in models

Huntington's Disease

Mutant huntingtin affects PI3K/AKT signaling[@twomey2023]:

• Impaired PI3K/AKT signaling contributes to neuronal dysfunction
• Therapeutic targeting of the pathway shows benefits in models
• Cross-talk with mutant huntingtin pathology

Multiple Sclerosis

The pathway affects oligodendrocyte survival and myelin repair[@flores2022]:

• PI3K/AKT promotes oligodendrocyte progenitor cell survival
• Myelin repair mechanisms require AKT signaling
• Immune modulation through PI3K/AKT affects disease course

Autophagy and Protein Homeostasis

mTORC1-Dependent Autophagy

AKT activates mTORC1, which regulates [autophagy](/mechanisms/autophagy)[@nixon2003]:

• mTORC1 inhibits [autophagy](/mechanisms/autophagy) initiation through ULK1 phosphorylation
• Autophagy inhibition by mTORC1 contributes to protein aggregate accumulation
• Dysregulated [autophagy](/mechanisms/autophagy) is a hallmark of neurodegenerative diseases

Therapeutic Implications

Modulating [autophagy](/mechanisms/autophagy) through PI3K/AKT has therapeutic potential[@rubinsztein2022]:

• mTOR inhibitors (rapamycin, everolimus) induce [autophagy](/mechanisms/autophagy)
• PI3K inhibitors have complex effects, depending on isoform selectivity
• Autophagy enhancers targeting downstream nodes show promise

Therapeutic Approaches

Pharmacological Strategies

| Compound | Target | Status | Notes |
|----------|--------|--------|-------|
| GSK-3 inhibitors | GSK-3β | Clinical trials | AD, bipolar disorder |
| Rapamycin | mTORC1 | Approved | Immunosuppression, being repurposed |
| AKT inhibitors | AKT | Clinical trials | Cancer applications |
| PI3K modulators | PI3K | Preclinical | Pathway modulation |

Growth Factor Therapies

Multiple growth factor approaches target PI3K/AKT signaling[@haggerty2023]:

• BDNF delivery through various routes
• IGF-1 therapy in clinical trials
• GDNF for PD has reached clinical testing[@nutt2013]

Gene Therapy

Viral vector-mediated gene delivery shows promise[@kells2024]:

• AAV-mediated AKT1 overexpression protects neurons
• Growth factor expression via viral vectors
• Combination approaches targeting multiple nodes

Cross-Pathway Interactions

AMPK-PI3K/AKT Axis

AMPK and PI3K/AKT share complex regulatory interactions[@hardie2012]:

• AMPK activation can inhibit mTORC1, complementing PI3K/AKT effects
• Energy sensing integrates with growth factor signaling
• Therapeutic targeting must consider cross-talk

Interaction with MAPK Pathways

PI3K/AKT and MAPK pathways intersect at multiple points[@huang2001]:

• Both pathways are activated by similar growth factors
• Cross-talk can be synergistic or antagonistic
• Combined targeting may provide benefits

Conclusion

The PI3K/AKT signaling pathway represents a central hub connecting neurotrophic factor signaling to neuronal survival, metabolic regulation, and protein homeostasis. Dysregulation of this pathway contributes to the pathogenesis of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative disorders. The pathway's importance is underscored by its multiple connections to key pathological features including amyloid-β toxicity, tau phosphorylation, α-synuclein aggregation, and [mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction-pd). Therapeutic strategies targeting this pathway, including growth factor therapies, GSK-3 inhibitors, and [autophagy](/mechanisms/autophagy) modulators, hold promise for disease-modifying treatments in neurodegeneration.

References